MBM-02

Tempol · Matrix Biomed, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MBM-02, covering 2021-05-05 to 2021-05-05. Get the full timeline:

Most recent: Clinical Trial Update: MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM) [Phase 2]